These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Incidence and clinical symptoms of Aeromonas-associated travellers' diarrhoea in Tokyo. Yamada S; Matsushita S; Dejsirilert S; Kudoh Y Epidemiol Infect; 1997 Oct; 119(2):121-6. PubMed ID: 9363009 [TBL] [Abstract][Full Text] [Related]
45. How can IBD be distinguished from IBS? Ginsburg PM; Bayless TM Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S152-4. PubMed ID: 18816655 [No Abstract] [Full Text] [Related]
46. [Computer-based health care research in the competence network inflammatory bowel disease. Handling of bowel diseases in general practice]. Heintze C; Esch T; Braun V Med Klin (Munich); 2006 May; 101(5):357-64. PubMed ID: 16685481 [TBL] [Abstract][Full Text] [Related]
47. Travel style is a major risk factor for diarrhoea in India: a prospective cohort study. Schindler VM; Jaeger VK; Held L; Hatz C; Bühler S Clin Microbiol Infect; 2015 Jul; 21(7):676.e1-4. PubMed ID: 25882361 [TBL] [Abstract][Full Text] [Related]
48. Does Helicobacter pylori play a role in inflammatory bowel disease? Nardone G; Rocco A; Budillon G Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):134-7. PubMed ID: 9615282 [TBL] [Abstract][Full Text] [Related]
49. Chronic inflammatory bowel disease in childhood. O'Gorman M; Lake AM Pediatr Rev; 1993 Dec; 14(12):475-80. PubMed ID: 8115285 [No Abstract] [Full Text] [Related]
51. Despite antibiotic treatment of travellers' diarrhoea, pathogens are found in stools from half of travellers at return. Lääveri T; Vilkman K; Pakkanen S; Kirveskari J; Kantele A Travel Med Infect Dis; 2018; 23():49-55. PubMed ID: 29702254 [TBL] [Abstract][Full Text] [Related]
52. Antimicrobial resistance profiles of Shigella dysenteriae isolated from travellers returning to the UK, 2004-2017. Terry LM; Barker CR; Day MR; Greig DR; Dallman TJ; Jenkins C J Med Microbiol; 2018 Aug; 67(8):1022-1030. PubMed ID: 29957175 [TBL] [Abstract][Full Text] [Related]
53. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome. Sprakes MB; Hamlin PJ; Ford AC Am J Gastroenterol; 2011 Jan; 106(1):166; author reply 166-7. PubMed ID: 21212757 [No Abstract] [Full Text] [Related]
54. [Inflammatory bowel disease in children and adolescents. When can the diagnosis be excluded without a referral to a pediatric gastroenterologist?]. Bennet R Lakartidningen; 1999 Jan; 96(1-2):49-51. PubMed ID: 9951250 [No Abstract] [Full Text] [Related]
55. Treatment of travellers' diarrhoea with fleroxacin: a case study. Steffen R; Jori J; DuPont HL; Mathewson JJ; Stürchler D J Antimicrob Chemother; 1993 May; 31(5):767-76. PubMed ID: 8335504 [TBL] [Abstract][Full Text] [Related]
56. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Smale S; Tibble J; Sigthorsson G; Bjarnason I Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):723-38. PubMed ID: 11566037 [TBL] [Abstract][Full Text] [Related]
57. Travel medicine: an Australian perspective. Leggat PA Travel Med Infect Dis; 2005 May; 3(2):67-75. PubMed ID: 17292008 [TBL] [Abstract][Full Text] [Related]
58. Travel illness in British package holiday tourists: prospective cohort study. Evans MR; Shickle D; Morgan MZ J Infect; 2001 Aug; 43(2):140-7. PubMed ID: 11676522 [TBL] [Abstract][Full Text] [Related]